Serial passage of the 64-2389 strain of type 3 parainfluenza virus in cercopithecus monkey kidney tissue cultures at low temperatures resulted in the selection of a variant which had a higher efficiency of plaque formation at 25 C than the parent line grown at 37 C. The cold variant, unlike the parent strain, plaqued readily at 25 C, and at 37 C it produced significantly larger plaques. Virus titers of the cold variant in hamster lungs were significantly lower and this was probably caused by the stimulation of interferon by the cold variant during the early phase of the infection. The cold variant, like the virus grown at 37 C, also induced the synthesis of interferon late in the infection. Hamsters responded to the intranasal inoculation of each virus line by the development of hemagglutinating-inhibiting antibodies in the sera.
Serial passage of the 64-2389 strain of type 3 parainfluenza virus in cercopithecus monkey kidney tissue cultures at low temperatures resulted in the selection of a variant which had a higher efficiency of plaque formation at 25 C than the parent line grown at 37 C. The cold variant, unlike the parent strain, plaqued readily at 25 C, and at 37 C it produced significantly larger plaques. Virus titers of the cold variant in hamster lungs were significantly lower and this was probably caused by the stimulation of interferon by the cold variant during the early phase of the infection. The cold variant, like the virus grown at 37 C, also induced the synthesis of interferon late in the infection. Hamsters responded to the intranasal inoculation of each virus line by the development of hemagglutinating-inhibiting antibodies in the sera.
Type 3 parainfluenza virus has been shown to be an important respiratory tract pathogen in both infants and young children throughout the world, producing such severe symptoms as croup, bronchiolitis, bronchitis, and pneumonia as well as upper respiratory tract disease (6, 8, 9) . The severity of the primary infection and the endemic and occasional epidemic pattern of infection during early childhood indicate a need for a vaccine that will protect the young infant.
The presence or absence of serum-neutralizing antibodies to certain viruses, such as measles and poliomyelitis which invade the circulatory system during development of the disease, has been used as an index of host resistance or susceptibility to such infections. Homologous serum-neutralizing antibody has been found to be highly effective in protecting against these diseases (1, 16) . The role of serum antibody in preventing reinfection of the upper respiratory tract by certain respiratory viruses is still uncertain (17) . Both adults and young children with serum-neutralizing antibody to type 3 parainfluenza virus can be reinfected; however, the resultant respiratory disease is usually less severe and is commonly associated with an upper respiratory tract infection (6, 9, 19 compared to similar neutralizing activity in nasal secretions of adults, the latter type of antibody was found to be a better indicator of host resistance to infection (26) . The intramuscular administration of an inactivated type 1 parainfluenza vaccine evoked high titers of serum-neutralizing antibody, but failed to stimulate production of antibodies in the nasal secretions. This failure to evoke nasal antibody was associated with the inability to protect against reinfection with this same virus. On the other hand, antibodies appeared in the nasal secretions of volunteers after intranasal inoculation of live virus, and these individuals were refractory to subsequent type 1 parainfluenza infection over a 6-to 8-month period.
In light of the above information, a search was initiated to select a "cold" variant of type 3 parainfluenza virus that would be immunogenic when given by the intranasal route and that would protect against a subsequent type 3 parainfluenza infection. In an attempt to attenuate a type 3 parainfluenza virus, a strain was serially passed in cercopithecus monkey kidney (CMK) tissue cultures at successively lower temperatures until it was adapted to grow at 25 C. Attenuation of certain viruses, such as poliovirus and measles virus, has been accomplished by selecting such variants during passages at low temperatures (12, 24) . This report describes both the passage history of this strain in CMK tissue cultures and the in vivo and in vitro markers that serve to distinguish it from the parent strain.
MATERIALS AND METHODS Animals. Male Syrian hamsters of appropriate age were obtained from our departmental breeding colony. Antibodies to parainfluenza type 1, 2, or 3 had not been detected in the sera of these animals.
Virus. The 64-2389 strain of type 3 parainfluenza virus, used in this study, was recovered from a child with an upper respiratory infection by Jose G. Canchola of the Children's Hospital of the District of Columbia. The strain was isolated and passed once in primary rhesus monkey kidney tissue culture by the above investigator. Then the virus was serially passed 45 times in our laboratory in CMK tissue cultures at 37 C before being propagated at lower temperatures.
The West Nile virus had a history of 28 passages in mouse brain before being lyophilized in 1951 as a 20% mouse brain suspension. The dried virus was reconstituted with phosphate-buffered saline (14) to make a 10% suspension, and was inoculated into the brains of 61-day-old hamsters to prepare a stock suspension which was inoculated into 28-day-old hamsters to prepare an interferon (IF) standard (27 (23) .
Serological tests. The micro hemagglutinationinhibition (HAI) test was used to determine the presence or absence of type 3 parainfluenza antibodies in hamster sera (7) . All sera were inactivated at 56 C for 30 min. They were initially absorbed with 25% kaolin and then with a 50% suspension of guinea pig red blood cells to remove nonspecific inhibitors.
Plaque test. The plaque procedure was a modification of that described by Coates and co-workers for plaquing respiratory syncytial virus on HEp-2 cell monolayers (10) . Virus was allowed to attach for 2 hr in a CO2 incubator at approriate temperatures. During this period, the plates were agitated gently to insure the even distribution of the inoculum over the monolayer. After attachment, a 5-ml overlay of the medium, containing 1% methyl cellulose (4,000 centipoises), was added to each culture without removing the inoculum and the cultures were then reincubated in a CO2 incubator. The fluid overlay was removed at appropriate times, depending on the incubation temperature, and the cell sheet was fixed with 10% Formalin.
After fixation, the cell sheets were stained with Giemsa (1:1,320) for 24 hr and the plaques were counted. An ocular micrometer was used in a Bausch & Lomb microscope to measure the dimensions of plaques (magnification 15 times).
Preparation of IF standard and assay. An IF standard was prepared by inoculating groups of 28-day-old hamsters with 105-5 TCID0o of West Nile virus (27) .
When the animals showed signs of paralysis, the brains were collected and homogenized as a 10% suspension in Hanks' balanced salt solution by use of a blendor. After centrifugation (600 X g), the supernatant fluids were dialyzed in the cold for 48 hr against glycine hydrochloride buffer (pH 2) and then against Eagle's basal medium (pH 7.2) containing 5% lactose. The precipitate formed during dialysis was removed by centrifugation at 600 X g. Brains from hamsters inoculated with uninfected tissue culture control fluids were processed in the same manner, and the resultant fluids were used as controls during the assay of the IF standard.
The brain suspensions and type 3 parainfluenza-infected lung suspensions were assayed for IF activity by the 50% plaque reduction method by use of a modification of the method of Stewart and Sulkin (27) . After incubating primary HK cultures for 18 hr with appropriate dilutions of the lung suspensions, the plates were washed twice and challenged with approximately 50 plaque-forming units of VSV. After an adsorption period of 1.5 hr at 36 C in an atmosphere of 5% C02, 5 ml of medium 199, containing 2% agamma calf serum, antibiotics, and 0.5% Ionagar, was added to each plate which was reincubated in 5% CO2 for 48 hr. The overlay was then removed and the plates were fixed in 10% Formalin before staining with Giemsa (1:1,320 25 and 37 C. The results of two such experiments indicated that the low-temperature variant had a higher relative plaquing efficiency than the parent virus, because the latter plaqued poorly at 25 C (Table 1) . This suggested that the continued passage of the 64-2389 strain at low temperatures resulted in the selection of a variant with an increased capacity to plaque at 25 C. This effect was not due to growth in CMK cultures per se, because higher passage levels of the parent line still had relatively low plaquing efficiencies.
Plaque size of the 64-2389 strain at 25 and 37 C. Since plaque size has been used as a marker to distinguish between virulent and attenuated strains of measles virus (22) and poliovirus (12) , the plaques, produced by the above virus passages, were measured in order to characterize further the virus grown at 25 C and at 37 C ( Table 2) . Virus from the 3rd and 18th passages at 25 C formed plaques at 37 C that were significantly larger than the parent plaques (Fig. 1) . These observed differences in size were statistically significant in each comparable experiment (P < 0.05 by the F test). In addition, virus from both passages at 25 C was capable of forming similar size plaques at 25 C, whereas the parent line produced so few plaques under the same conditions that their size could not be determined accurately.
Pathogenesis of type 3 precipitous drop in virus titer in the lungs on the 5th through the 7th day. Antibody titers increased up to the 10th day and thereafter remained relatively constant. Histological examination of infected lungs indicated that there was no difference in either the extent or number of animals exhibiting focal areas of consolidation.
IF-like activity was initially detected in the lungs of Para25-infected hamsters on the 1st day after infection, and then this activity dropped to undetectable levels for the next 2 days (Fig. 3) . Although no IF-like activity was detected in the lungs of Para37-infected hamsters on the first 3 days, low levels of IF activity were found on the 4th and 5th days after infection with either virus variant.
The evidence that the interfering activity in the hamster lung is actually IF fection (Fig. 4) . The virus titer of both Para25 and Para37 rose rapidly in the lungs of 32-day-old animals on the 1st day. Titers of the cold variant dropped significantly on the 2nd day, whereas Para37 virus titers continued to increase to a maximum on the 3rd day. Lungs from Para37-infected hamsters, as in the case of the older hamsters, contained 10 to 100 times more virus from the 2nd to the 4th day after infection than the Para25-infected lungs. Virus titers dropped to undetectable levels on the 6th day or at a time when HAI antibody was first found in the sera. Antibody titers continued to increase to the 14th day and remained relatively constant thereafter. Both large and small areas of consolidation and some bronchitis were observed in the lungs when either virus line was used; however, these lesions could not be distinguished histologically one from another. The per cent of animals in which lesions were found was similar to that seen in older hamsters.
DISCUSSION
The results of these studies indicated that serial passage of the 64-2389 strain of type 3 parainfluenza virus in CMK tissue cultures at low temperatures resulted in the selection of a variant which could be differentiated from its progenitor by in vivo and in vitro markers. The 64-2389 cold variant demonstrated an increased plaquing efficiency at 25 C in comparison to the line propagated at 37 C. Similar results were reported by Friedewald and co-workers (15) for respiratory syncytial virus grown at 26 C. These workers demonstrated a direct relationship between an increased plaquing efficiency at 28 C and a decreased infectivity of their cold variant for adult volunteers, which indicated that this strain was less virulent than the parent virus grown at 34 C.
The emergence, after low temperature passage, of a variant which produced larger plaques than the parent strain is not unique with this study. When types 1, 2, and 3 polioviruses were adapted to grow at 30 C in CMK tissue culture, they formed larger plaques on HEp-2 monolayers than the parent viruses grown at 37 C, and these cold poliovirus variants were significantly less virulent for monkeys (12) . Similarly, the 64-2389 cold variant in this study produced larger plaques than its progenitor at 37 C; however, unlike the parent strain, this variant was capable of plaquing very efficiently at 25 C. The above differences in efficiency of plaque formation and plaque size suggest that a genetic change occurred during the low temperature passage of this virus. It is important to note that the plaquing characteristics for the 64-2389 strain were evident in passages made before the terminal dilution series (passages 4 through 8 at 25 C) and therefore selective forces, such as an unnatural host and low temperatures, were as responsible as the terminal dilution procedures for its selection. Furthermore, continued passage of the parent strain in CMK tissue culture at 37 C did not result in the appearance of a variant with such plaquing characteristics.
IF titers closely followed the rise in Para25 virus titers in the lungs. The early appearance of IF in the lungs of these hamsters was probably responsible for the early suppression of Para25 virus multiplication, since antibody could not be detected in the sera until 5 or 6 days later. The presence of IF at this time and place is consistent with the significant role that this compound plays during the recovery from respiratory infections (2, 11, 17) , since IF can diffuse out of infected cells and protect neighboring cells from subsequent infection (18) . In a similar study, Isaacs and Hitchcock (17) infected mice intranasally with the PR8 strain of influenza virus and found that virus titers in the lungs decreased several days before antibody was demonstrable but at a time when IF was present in the lungs in high titer. Liu and co-workers (20) 
